SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy Participants

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This is a Phase 1 study to test the safety and drug effects of MDI-2517 when given once in healthy volunteers.
Epistemonikos ID: 59823b2ad17eacd2d85e1c9d7347230d26d2dc89
First added on: Apr 17, 2025